Weisel, Katja Dimopoulos, Meletios Athanasios Van de Donk, Niels Ramasamy, Karthik Gamberi, Barbara Streetly, Matthew Offidani, Massimo Bridoux, Frank de la Rubia, Javier Kueenburg, Elisabeth others, Phase 2 Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (Pts) With Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): An Updated Safety Analysis, Clinical Lymphoma Myeloma and Leukemia, (17), e145, 2017, Elsevier,